ORGANOGENESIS HOLDINGS INC. Cash and Cash Equivalents, Period Increase (Decrease)
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$123.18 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-11-09
- ORGANOGENESIS HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$61.71K.
- ORGANOGENESIS HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$35.08K.
- ORGANOGENESIS HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$26.39K.
- ORGANOGENESIS HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $8.16K, a 99.06% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$914.18K, a 200.02% decline from fiscal 2016.
- ORGANOGENESIS HOLDINGS INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $914.01K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 1 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2018-09-30 | -$61.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$96.79K derived: sum of 2 quarters · filed 2018-11-09 | -$123.18K 10-Q · filed 2018-11-09 | -$115.02K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2018-06-30 | -$35.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$61.48K 10-Q · filed 2018-08-07 | -$53.32K derived: sum of 3 quarters · filed 2018-08-07 | -$222.05K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2018-03-31 | -$26.39K 10-Q · filed 2018-05-10 | -$18.23K derived: sum of 2 quarters · filed 2018-05-10 | -$186.97K derived: sum of 3 quarters · filed 2018-11-09 | -$386.71K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-12-31 | $8.16K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$160.57K derived: sum of 2 quarters · filed 2018-11-09 | -$360.31K derived: sum of 3 quarters · filed 2018-11-09 | -$914.18K 10-K · filed 2018-03-14 | |
| 2017-09-30 | -$168.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$368.47K derived: sum of 2 quarters · filed 2018-11-09 | -$922.34K 10-Q · filed 2018-11-09 | -$54.11K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | -$199.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$753.61K 10-Q · filed 2018-08-07 | $114.62K derived: sum of 3 quarters · filed 2018-08-07 | $180.40K derived: sum of 4 quarters · filed 2018-08-07 | |
| 2017-03-31 | -$553.87K 10-Q · filed 2018-05-10 | $314.37K derived: sum of 2 quarters · filed 2018-05-10 | $380.14K derived: sum of 3 quarters · filed 2018-05-10 | ||
| 2016-12-31 | $868.23K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $934.01K derived: sum of 2 quarters · filed 2018-03-14 | $914.01K 10-K · filed 2018-03-14 | ||
| 2016-09-30 | $65.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $45.77K 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | -$20.00K 10-Q · filed 2017-08-11 | ||||
| 2015-12-31 | $126.06K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |